Skip to main content
  • Conference proceedings
  • © 1993

Human Apolipoprotein Mutants III

Diagnosis and Treatment

Part of the book series: Nato ASI Subseries H: (ASIH, volume 73)

Buying options

eBook USD 119.00
Price excludes VAT (USA)
  • ISBN: 978-3-642-84634-2
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
Softcover Book USD 159.00
Price excludes VAT (USA)

This is a preview of subscription content, access via your institution.

Table of contents (25 papers)

  1. Front Matter

    Pages I-XI
  2. Enzymes and Apolipoproteins in the Diagnosis of Disease

    1. Lipoprotein lipase: Gene variants and coronary atherosclerosis

      • Raj K. Mattu, David J. Galton
      Pages 1-11
  3. Structural and Functional Relationships in Apolipoproteins

    1. Lipid Transport by Apolipoprotein AI: Structure and Function

      • E. L. Gong, A. V. Nichols, A. R. Tall
      Pages 31-41
    2. Characterization of Lipoprotein Particles Containing Apolipoprotein A-IV

      • G. R. Castro, N. Duverger, P. Duchateau, J. C. Fruchart
      Pages 43-52
    3. Structural and Functional Properties of Apo A-I Variants in Reconstituted HDL

      • A. Jonas, A. von Eckardstein, W. W. Mantulin, G. Assmann
      Pages 53-65
    4. Crystal Structures of the Common Apolipoprotein E Variants: Insights into Functional Mechanisms

      • Mark R. Wardell, Charles Wilson, David A. Agard, Robert W. Mahley, Karl H. Weisgraber
      Pages 81-96
    5. Analysis of Apolipoprotein E Function in Adrenal Cells: Effects on Cholesterol Metabolism and Signal Transduction Pathways

      • David L. Williams, Margaret M. Prack, M. Nicosia, J. T. Gwynne, Mary E. Reyland
      Pages 97-106
  4. Animal Models in the Apolipoprotein Mutant Research

    1. Spontaneous Hypercholesterolemia in Pigs

      • Alan D. Attie, Robert J. Aiello, Scott T. Cooper, Patricia J. Uelmen
      Pages 107-112
  5. Recombinant Apolipoproteins as Drugs

    1. Apolipoproteins as “Drugs”: Current Status

      • Cesare R. Sirtori
      Pages 121-133
    2. Non-Mammalian Host Systems for the Expression of Mammalian Apolipoproteins

      • S. L. Sturley, D. G. Gretch, P. D. Friesen, M. R. Culbertson, N. Beckage, A. D. Attie
      Pages 135-143
    3. Recombinant Human Proapolipoprotein A-I: Experimental Strategies for the Production of an Authentic Molecule

      • N. Moguilevsky, F. Varsalona, J.-P. Guillaume, C. Roobol, A. Bollen
      Pages 145-163
  6. Molecular Abnormalities of Apolipoproteins

    1. Apolipoprotein B: Genetic Variants Provide Insight into Structure and Function

      • Philippa Talmud, Alison Dunning, Steve Humphries
      Pages 183-194
    2. The Mutations of Apolipoprotein B Gene Causing Hypobetalipoproteinemia: Molecular and Functional Abnormalities in Apo B-87Padova

      • C. Gabelli, C. Bilato, S. Martini, G. E. Tennyson, H. B. Brewer Jr, G. Crepaldi et al.
      Pages 195-206
    3. Causes Underlying the Reduced Response to Simvastatin Treatment in Hypercholesterolemic Patients

      • Alberto Corsini, Maria Mazzotti, Tiziano Zanelli, Patrizia Uboldi, Domenico Sommariva, Franco Pazzucconi et al.
      Pages 207-229

About this book

Hopes to develop apolipoproteins for diagnostic or, even better, therapeuticpurposes are growing. Areas of use may range from arterial disease to AIDS, fertilization programs, neurological or inflammatory disorders, and the like. However, these young members of the large family of circulating proteins still deserve careful study, both in terms of structural and functional properties and of their pathological changes. In addition, related molecules, in particular belonging to the family of enzymes, such as lipases and acyltransferases, offer exciting insight into the mechanisms of regulation of lipid transport and exchange. Described hereis the use of apolipoproteins and enzymes in the diagnosis of coronary and cerebrovascular disease. Structural and functional changes of apolipoproteins are related to lipid transport and binding to different receptors. Further, the development of apolipoprotein drugs and their possible clinical use for vascular and non vascular disease is discussed and finally an overview on lipoprotein transformation processes, expression systems and natural mutants is provided.

Keywords

  • AIDS
  • Apolipoproteine
  • Arteriosklerose
  • Atherosklerose
  • Cardiology
  • Kardiologie
  • Koronarkrankheit
  • Lipid
  • apolipoproteins
  • arteriosclerosis
  • atherosclerosis
  • coronoary disease
  • enzymes
  • proteins
  • regulation

Editors and Affiliations

  • Center E. Grossi Paoletti, Institute of Pharmacological Sciences, University of Milano, Milano, Italy

    Cesare R. Sirtori, Guido Franceschini

  • Molecular Disease Branch, National Institutes of Health, NHLBI, Bethesda, USA

    Bryan H. Brewer

Bibliographic Information

Buying options

eBook USD 119.00
Price excludes VAT (USA)
  • ISBN: 978-3-642-84634-2
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
Softcover Book USD 159.00
Price excludes VAT (USA)